The efficacy and effectiveness of ACE inhibitors were investigated for several diseases, among which cardiovascular disease was the most widely studied condition (n = 97,872, from 246 studies), followed by cerebrovascular disease (n = 9,589, from 18 studies) and endocrine disorders (n = 7177, from 37 studies) (Figure 3). Here, ACE is linked to cerebrovascular disorder.